ArticleWorld journal of diabetes2024

Safety of teplizumab in patients with high-risk for diabetes mellitus type 1: A systematic review.

Venkata Buddhavarapu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.